959748-80-2

Basic information

• Product Name: 5-chloro-N-(5-chlorothiazol-2-yl)-2-methoxybenzamide
• Synonyms: 5-chloro-N-(5-chlorothiazol-2-yl)-2-methoxybenzamide
• CAS NO: 959748-80-2
• Molecular Weight: 303.169
• Mol File: 959748-80-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-chloro-N-(5-chlorothiazol-2-yl)-2-methoxybenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloro-N-(5-chlorothiazol-2-yl)-2-methoxybenzamide(959748-80-2)
• EPA Substance Registry System: 5-chloro-N-(5-chlorothiazol-2-yl)-2-methoxybenzamide(959748-80-2)

Safety Data

• Hazardous Substances Data: 959748-80-2(Hazardous Substances Data)

Upstream product

• 3438-16-2 5-chloro-2-methoxybenzoic acid 
• 55506-37-1 2-amino-5-chloro-thiazole hydrochloride 

Downstream Products

• 1065641-09-9 5-chloro-N-[(2Z)-5-chloro-3-(1,3-thiazol-4-ylmethyl)-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide 
• 959748-79-9 5-chloro-N-[(2Z)-5-chloro-3-(tetrahydrofuran-2-ylmethyl)-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide 
• 959749-13-4 5-chloro-N-[(2Z)-5-chloro-3-[(2R)-tetrahydrofuran-2-ylmethyl]-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide 

Relevant articles and documents

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF

The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, formula (I). wherein R1, R2, R3, R4, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, formula (II). wherein R1a, R2a, Rx, and n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

The present application relates to thiazolylidene containing compounds of formula (I) wherein R1, R2, R3, R4, L2 and A are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.